interleukin-17 receptor

Known as: Interleukin 17 Receptor, CDw217 Antigen, Cdw217 Antigens 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2018
0120142018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Brodalumab (Kyntheum®) is a human anti-interleukin-17 receptor A (IL-17RA) monoclonal antibody available for use in patients with… (More)
Is this relevant?
2016
2016
Interleukin-17 receptor A (IL-17RA) has been recognized as a valuable biomarker for diverse diseases, including autoimmune… (More)
Is this relevant?
2015
2015
BACKGROUND Primary graft dysfunction (PGD), with an incidence of 11% to 57%, is a major cause of morbidity and mortality within… (More)
Is this relevant?
Review
2015
Review
2015
: Interleukin-17 receptor A (IL-17RA) is responsible for both IL-17A and IL-25 (IL-17E) signaling pathways. Current evidences… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2014
2014
Brodalumab, a human monoclonal IgG2-antibody, acts as a potent antagonist at the interleukin-17 receptor A, which is important in… (More)
  • table 2
  • table 1
  • figure 1
  • figure 2
  • table 3
Is this relevant?